AMBEV S.A. current report, Q4 FY2022

Business Context and Reporting Period

This Form 6-K filing by Ambev S.A. covers the month of November 2022. The report is submitted pursuant to Rule 13a-16 of the Securities Exchange Act of 1934 and complies with Article 11 of CVM Instruction # 358/2002. The filing specifically details transactions regarding the company's outstanding shares held in treasury.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on treasury share transactions.

Metric Value
Treasury Shares (Initial Balance) 8,643,466
Treasury Shares (Final Balance) 8,634,764
Shares Delivered (Restricted) 8,702
Transaction Price per Share R$ 16.31
Total Transaction Volume R$ 141,929.62

Material Changes

During the reporting period, the company executed a direct transaction with the company involving the delivery of restricted shares. This resulted in a net reduction of treasury shares from 8,643,466 to 8,634,764. No other securities or derivatives operations took place during the month.

Guidance, Outlook, and Risks

The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is a statutory disclosure of specific treasury share movements and does not contain forward-looking statements or operational analysis.

Investor Verification Checklist

  • Verify the impact of the 8,702 restricted share deliveries on total outstanding share count.
  • Confirm the classification of the R$ 16.31 price as a fair market value or a predetermined restricted stock price.
  • Review the full annual report (Form 20-F) for comprehensive financial performance data not included in this 6-K.